The mobility afforded by the wearable Novacor LVAS provides the possibility for the recipients to leave the hospital, with undoubted improvements in their quality of life. A staged program for discharging LVAS recipients from the hospital has been set up at the Policlinico San Matte0 of Pavia together with the Rehabilitation
Introduction
Despite the enormous improvements in the medical treatment of end stage heart failure and the effectiveness of heart transplantation in providing full rehabilitation of totally disabled individuals, approximately 25% of potential transplant recipients die due to a *Corresponding author. The range of available devices for mechanical support includes centrifugal pumps with continuous flow, pulsatile systems with paracorporeal ventricles activated by pneumatic energy and left ventricular assist devices electrically powered, heterotopitally implantable with wearable controllers. Together with the improvement in the engineering, the experience acquired in large series of patients mechanically supported for long periods of time, led to a progressive evolution in recipient management [2] [3] [4] 8] . Even with S46 M. Vigand et al. /European Journal of Cardio-thoracic Surgery I1 Suppl. (1997) S45-S50 the console-based systems characterized by limited mobilization, attempts were made to reduce the ICU stay and, in selected cases, to transfer the patients into 'family houses' specifically equipped to combine patient safety and acceptable quality of life [l] . The wearable controller 'almost eliminated the mobility limitations opening a broad range of implications. involving patient management, indications, timing of implantation and, eventually, the real need of transplantation [6] . Nowadays, not only is mechanical assistance considered a method to keep alive moribund transplant candidates, but. more consistently, it is a reliable way to stabilize and rehabilitate patients in end stage cardiac failure [7] , in some cases offering the choice between an elective transplantation and a chronic support. Moreover, the possibility of reducing ICU stay and hospitalization of these patients improves their quality of life reducing at the same time the costs of medical care. Following the above considerations, a program of staged discharge of LVAS recipients has been set up at the Policlinico S. Matte0 of Pavia in collaboration with the Heart Failure Unit of the Rehabilitation Center of Montescano In this report we analyze this experience, discussing the aspects regarding rehabilitation, discharge and chronic management.
Materials and methods
From November 1992 to December 1995, 11 patients underwent mechanical assistance with Novacor LVAS. The characteristics of patients are illustrated in Table 1 .
The surgical technique for LVAS implantation, as described elsewhere [5] , implies: (1) complete opening of the left anterior diaphragmatic costal insertions to allow easy control of any potential bleeding site and mobilization of the pump to facilitate deairing; (2) insertion of the apical conduit first, to obtain an orthodromic easy and reliable deairing; (3) the use of cardioplegic arrest during apical cannulation and exploration for thrombi and trabeculae at the site of apical cannulation. BSA, body surface area (m*); CM, cardiomyopathy; IHD, ischemic heart desease; IABP, intra-aortic balloon pump.
The first two patients were supported with the console-based unit. With the availability of the wearable controller the possibility of a complete mobilization prompted us to develop a more ambitious program of rehabilitation with discharge as an end point. ICU-stay was then limited to the respiratory and circulatory stabilization. Patients 3, 4 and 5 were managed in the ward of cardiac surgery with daily outdoor hospital walks and occasional out-of-hospital excursions.
Starting with Patient 6, a staged program for discharging LVAS recipients from the hospital has been set up together with the Rehabilitation Center of Montescano and Baxter Novacor Service support, in order to proceed smoothly towards patient's self sufficiency and to minimize any associated risk. Since April 1995, four patients (three males, one female) were transferred to the rehabilitation center (mean time of circulatory support before discharge: 70 days, range 43-111): three of them were eventually discharged to home.
The Out of Hospital Program includes the following steps: (1) in-hospital stay, for device implantation, hemodynamic stabilization and surgical problems resolution. During this period passive and active mobilization is carried out. At the end of this phase a right heart catheterization is performed to determine the baseline hemodynamic situation; (2) discharge to Rehabilitation Center, to complete the physical training and psychological preparation and to-test patients ability to carry on an autonomous life on device. The results are recorded by light heart catheterization and cardopulmonry exercise test (monthly); (3) discharge to home, when the patient is stable and confident with the device. The check of patient condition is performed through the patient diary review, patient interview and medical and nursing evaluation once per week at the Rehabilitation Center.
Simple criteria of eligibility must be fulfilled to move to the next step (Fig. 1 ). The patient is eligible for discharge to Rehab Center when he is clinically stable, with healed wounds and stabilized anticoagulation therapy. Besides these basic requirements, in order to be discharged to home, the patient must also be self sufficient in medical and personal care, physically trained for bearing normal exercise, psychologically prepared and compliant. Living within a radius of 100 km from the hospital (or in a 2-h travel distance) and the continuous presence of a trained caregiver at home have been considered only as optional criteria for inclusion in the program. Several excursions with and without LVAS team member are encouraged before final discharge to home, starting with 2-4 week-end trips home and progressively increasing the home stay until an individual-based definitive discharge.
The equipment that has been used for supporting the patients out of the hospital consists of a Personal Monitor with a standby power source, a battery Cardio-thoracic Surgery I I Suppl. (1997) charger and a set of rechargeable batteries (Baxter. Novacor Divis., Oakland, CA).The Personal Monitor provides power to the wearable controller of the pump during tethered operation, for instance during sleep or periods of rest. In addition. it provides information on pump operation and system alarm status. Moreover, in case of alarm the monitor shows illuminated icons to explain very quickly to the patient what is happening and the alarm messages are coded by numbers in order to make easier and clearer the exchange of information between the patient and the LVAS operator on call, even if the patient or the relatives do not have a high level of education. The patient is provided with several spare parts for addressing immediately any abnormal operation. Different accessories for wearing the pump controller and the batteries are available, such as a handbag, a belt with suspenders and a waistcoat. for better adapting to the different patients' requests and to the activities they perform in a normal day. Every move towards a reduced presence of specialized personnel includes an appropriate training of the patient and relatives and a technical checkout of the needed equipment. The technical training is designed in a step-by-step) way. where the patient, once trained, takes an active part in training his relatives. The first session of the training is performed before discharging the patient to the Rehabilitation Center and it includes the principles of left ventricular support, routine management of the LVAS equipment and of the power supply and guidelines for a correct response to alarms and troubleshooting. At the Rehabilitation Center, the patient is encouraged to take care completely of his equipment, reporting to the personnel only abnormal situations. Before discharging the patient to home, the training session is repeated in the presence of the patient's relatives; emergency and non-emergency contact information are provided too. The patient is instructed on how to keep a simple diary, where he is asked to report the duration of the batteries during a week of normal activities at home and where he can annotate any observation on the pump operation. Periodic review of the adequacy of training is performed during the check visits, both at the Rehabilitation Center and at patient's home.
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Technical evaluation takes place at the Rehabilitation Center once every two weeks (alarm test, check for current alarm conditions; adjust control parameters and alarm limits if appropriate; check condition of air filter, cables and connectors and replace if necessary) and technical inspections at home twice per year (alarm test of the Personal Monitor; check of batteries; check of present charge level of standby power source; routine maintenance of cables, connectors and fan filter). Control parameters of the LVAS are recorded only in case of alarms or abnormal sponsible for providing on call (all hours).
Results
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operation. The hospital is reone LVAS operator available Hemodynamic performance: hemodynamic parameters pre and post LVAS implantation are listed in Table  2 . As expected, CI and PCWP reached normal values. Mean pulmonary pressure and pulmonary vascular resistances significantly lowered. Transpulmonary gradient decreased slowly, reflecting a relative refractoriness to vasodilation of the pulmonary arteriole. At the beginning of the rehabilitation period all patients were in NYHA class 1 in respect to their daily life.
Attendance to the scheduled physical training program (5 day/week of cycle/treadmill sessions, calysthenits, stretching exercises): the mean percentage of attendance was 65% (range 29-90). The youngest patient was the most interested in physical training, whereas the relatively old (62 year) lady was satisfied with her baseline conditions. No complications occurred during physical sessions. Cardiopulmonary exercise test: the baseline test at the beginning of the training program showed in some patients a high degree of physical deconditioning (peak VO, 18.2, 11.7, 6.7, 17 ml/kg/min). In Table 3 as an example the result of Patient 6 is reported.
Medications
All patients were compliant with the anticoagulation and antiplatelet therapy. No significant out of range values of prothrombin activity were recorded. ACE inhibitors to keep systolic arterial pressure below 150 mmHg were required in every patient. In one case a HR, heart rate (bpm); SAP/DAP, systolic arterial pressure/diastolic arterial pressure (mmHg); PO, pump output (ljmin); PR, pump rate (bpm); VO,/kg, specific oxygen consumption (ml/kg/min).
double therapy with ACE-inhibitors and calcium channels blockers was necessary. At the moment of the discharge to home none of the patients was on digoxin and/or diuretics. Psychological implications: the improvement in health status overcame any discomfort; the device was accepted and the noise was felt to be a marker of safety. Three patients were eventually discharged to home, whereas the most recently implanted one is still in the Rehabilitation Center. One patient was successfully transplanted after 142 days of support. In Table 4 the period of time spent in ICU, ward, rehabilitation center and home is illustrated. Complications: only one out of the four dehospitalized patients showed complications after being discharged to home. The adverse events that occurred to him were: one TIA, despite antiaggregation and normal range of anticoagulation (prothrombin activity range: 20-40%); local infection at the exit site of the transcutaneous cable sustained by a multiresistant Staphylococchus aureus requiring one readmission for IV treatment.
Technical issues
Neither mechanical nor electrical failure of any part of the system have occurred. The most frequent technical issues that were addressed involved the power supply management, and particularly the best way to store and recharge batteries when room temperature is too hot or too cold at the patient's home, where, most times, air conditioning is not available. 
Quality of life
All patients positively accepted the possibility of leaving the hospital. The relatives were trained in the management of the 'device and reassured about the availability of on-call specialized staff. The involvement in home activities and local social life was positive in every case. One patient enjoyed his first plane trip to participate in a show on national television; as a farmer he also contributes to the family work. The younger patient, eventually transplanted, reported a satisfactory sexual life with his partner.
The acceptance of these patients by the family and acquaintances is usually good. The compliance towards scheduled checks and therapy is excellent.
Discussion
The availability of advanced devices which allow complete mobilization is progressively modifying the concept of mechanical support in end stage heart failure. One of the major limits of the console based systems was the need of a permanent ICU or hospital stay for the patients, with an extremely unfavourable cost-benefit ratio and a poor quality of life. Moreover, because the problem of organ scarcity is not influenced by any system of bridge to transplantation, the only expected result was to keep alive some dying candidates occupying rare and expensive hospital resources. As a consequence of these remarks, the indication to mechanical assistance was limited to extremely selected patients at the very end of their possibility of survival and the duration of support was minimized in order to reduce both the incidence of complications and the costs. Only few centers exceptionally had the possibility of simultaneous assistance so that this activity was more an exercise of sophisticated medical technology than an established method of treatment.
Mobility, the characteristic that differentiates the wearable systems from the console-based ones, has reduced the majority of the limitations for an extensive application of these devices [5, 9] , eventually transforming mechanical assistance into a cost-saving procedure not necessarily with transplantation as the end point [3, 6] . The implantation can be performed earlier and the device left in place until a complete rehabilitation is achieved. The number of patients simultaneously supported can be significantly increased with limited influence on hospital facilities. Even if the number of transplantations performed is not modified the necessity of emergency transplantation is significantly reduced as well as the amount of status 1 bed ridden and ICU dependent patients. This initial experience of staged discharge of Novacar LVAD recipients is satisfactory: no complications amenable to the protocol were recorded. Patients quality of life was considerably improved with respect to the pre-implant phase due to the almost complete restoration of social and family life. The need for medications is limited to antithrombotic and antihypertensive therapy. Systemic hypertension is frequently observed after the second week of LVAS implantation, probably related to the new hemodynamic conditions and to neurohumaral factors that need to be investigated. Recipients' compliance to the program is of the maximum importance.
However. in our series, achieving a complete adhesion to the protocol has not been difficult due to the immediate perception of benefits by the patients. Moreover, the program has been successfully accepted by the patients because it is simple and asks for very few restrictions in their normal life-style as well as being safe and reliable.
This encouraging experience may suggest a more extensive use of wearable LVAS in heart transplant programs to improve candidates' survival and quality of life with limited impact on health costs. In same selected cases we are approaching the goal of an alternative to heart transplantation or medical therapy for end stage heart failure [lo] .
